🔎 Trials Near Me

መነሻ › የጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) › Washington › Seattle

በSeattle፣ WA ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ 10 ጥናቶች በSeattle እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Facility, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06726161

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center- Montlake, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07227012

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Local Institution - 0083, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07291076

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Fred Hutchinson Cancer Center, University of Washington, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT04864054

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06921785

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Washington School of Medicine, Seattle
እድሜ 8 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT05503797

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

ተሳታዮችን በመፈለግ ላይ
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁን 2026 · NCT05486572

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Virginia Mason Medical Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኤፕሪ 2026 · NCT05440708

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Seattle Children's Hospital, Seattle
እድሜ ከ1 እስከ 26 · ሁሉም ጾታዎች · የተሻሻለው በ17 ፌብሩ 2026 · NCT07148050

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Seattle
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

በሌሎች ከተሞች ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ ጥናቶች

በSeattle ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።